Ken Griffin A Tyr Pharma Inc Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 7,500 shares of LIFE stock, worth $15,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,500
Previous 700
971.43%
Holding current value
$15,000
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding LIFE
# of Institutions
60Shares Held
33.5MCall Options Held
7.5KPut Options Held
3.2K-
Federated Hermes, Inc. Pittsburgh, PA10.2MShares$20.3 Million0.05% of portfolio
-
Logos Global Management LP San Francisco, CA3.1MShares$6.2 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.65MShares$5.3 Million0.0% of portfolio
-
Tikvah Management LLC Charlotte, NC2.46MShares$4.92 Million1.51% of portfolio
-
Woodline Partners LP San Francisco, CA1.68MShares$3.36 Million0.03% of portfolio
About aTYR PHARMA INC
- Ticker LIFE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,625,000
- Market Cap $57.3M
- Description
- aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...